Rich and middle-income countries have received nearly all of the available COVID-19 vaccines so far. Now there’s a push for pharmaceutical companies to waive vaccine patents so poorer countries can make their own.
Copyright 2021 NPR
Rich and middle-income countries have received nearly all of the available COVID-19 vaccines so far. Now there’s a push for pharmaceutical companies to waive vaccine patents so poorer countries can make their own.
Copyright 2021 NPR